Department of MedicineFeed

People

  1. Schram
    Schram
  2. Koutcher
    Koutcher
  3. Gorsky
    Gorsky
  4. Markova
    Markova
  5. Rathkopf
    Rathkopf
  6. Abou-Alfa
    Abou-Alfa
  7. Taur
    Taur
  8. Ponce
    Ponce
  9. Papadopoulos
    Papadopoulos
  10. Beattie
    Beattie
  11. Glickman
    Glickman
  12. Jawed
    Jawed
  13. Gu
    Gu
  14. Mato
    Mato
  15. Jones
    Jones

Description

Publications

  1. Journal of Clinical Oncology (4443)
  2. Blood (2572)
  3. Cancer Research (1106)
  4. Annals of Oncology (886)
  5. Clinical Cancer Research (702)
  6. Biology of Blood and Marrow Transplantation (679)
  7. Cancer (469)
  8. Journal of Thoracic Oncology (386)
  9. International Journal of Radiation Oncology, Biology, Physics (367)
  10. Journal of the National Comprehensive Cancer Network (327)

Publishers

  1. American Society of Clinical Oncology (4640)
  2. Elsevier Inc. (3373)
  3. American Society of Hematology (2700)
  4. Nature Publishing Group (1791)
  5. Oxford University Press (1317)
  6. Springer (1246)
  7. Wiley Blackwell (1194)
  8. American Association for Cancer Research (1087)
  9. Elsevier Science, Inc. (1063)
  10. Lippincott Williams & Wilkins (896)

Types of Work

Ajax loader

Recent Works

  1. Re: Utility of routine preoperative (18)F-fluorodeoxyglucose positron emission tomography/computerized tomography in identifying pathological lymph node metastases at radical cystectomy - Reply by authors
    Correspondence

    Dason, S.; Wong, N. C.; Donahue, T. F.; Meier, A.; Zheng, J.; Mannelli, L.; Di Paolo, P. L.; Dean, L. W.; McPherson, V. A.; Rosenberg, J. E.; more...
    Journal of Urology (2021)

    Fulltext@MSK | Save
  2. A tumor-agnostic TCR-mimic CAR-T cell specific for NDC80 targets multiple hematological malignancies
    Meeting Abstract

    Klatt, M. G.; Dao, T.; Yang, Z.; Liu, J.; Mun, S. S.; Dacek, M. M.; Luo, H.; Gardner, T. J.; Bourne, C.; Peraro, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  3. MagnetisMM-1: A study of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA)-targeted, CD3-engaging bispecific antibody, for patients with relapsed or refractory multiple myeloma (MM)
    Meeting Abstract

    Levy, M.; Bahlis, N.; Raje, N.; Costello, C.; Dholaria, B.; Solh, M.; Tomasson, M.; Dube, H.; Damore, M.; Lon, H. K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save